» Articles » PMID: 25276814

Hyaluronan-phosphatidylethanolamine Polymers Form Pericellular Coats on Keratinocytes and Promote Basal Keratinocyte Proliferation

Overview
Journal Biomed Res Int
Publisher Wiley
Date 2014 Oct 3
PMID 25276814
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Aged keratinocytes have diminished proliferative capacity and hyaluronan (HA) cell coats, which are losses that contribute to atrophic skin characterized by reduced barrier and repair functions. We formulated HA-phospholipid (phosphatidylethanolamine, HA-PE) polymers that form pericellular coats around cultured dermal fibroblasts independently of CD44 or RHAMM display. We investigated the ability of these HA-PE polymers to penetrate into aged mouse skin and restore epidermal function in vivo. Topically applied Alexa(647)-HA-PE penetrated into the epidermis and dermis, where it associated with both keratinocytes and fibroblasts. In contrast, Alexa(647)-HA was largely retained in the outer cornified layer of the epidermis and quantification of fluorescence confirmed that significantly more Alexa(647)-HA-PE penetrated into and was retained within the epidermis than Alexa(647)-HA. Multiple topical applications of HA-PE to shaved mouse skin significantly stimulated basal keratinocyte proliferation and epidermal thickness compared to HA or vehicle cream alone. HA-PE had no detectable effect on keratinocyte differentiation and did not promote local or systemic inflammation. These effects of HA-PE polymers are similar to those reported for endogenous epidermal HA in youthful skin and show that topical application of HA-PE polymers can restore some of the impaired functions of aged epidermis.

Citing Articles

Intradermal Treatment with a Hyaluronic Acid Complex Supplemented with Amino Acids and Antioxidant Vitamins Improves Cutaneous Hydration and Viscoelasticity in Healthy Subjects.

Siquier-Dameto G, Boadas-Vaello P, Verdu E Antioxidants (Basel). 2024; 13(7).

PMID: 39061838 PMC: 11274003. DOI: 10.3390/antiox13070770.


Nano-BTA: A New Strategy for Intravesical Delivery of Botulinum Toxin A.

Liu Q, Liao L Int Neurourol J. 2022; 26(2):92-101.

PMID: 35793987 PMC: 9260331. DOI: 10.5213/inj.2142124.062.


Epidermal Hyaluronan in Barrier Alteration-Related Disease.

Evrard C, Lambert de Rouvroit C, Poumay Y Cells. 2021; 10(11).

PMID: 34831319 PMC: 8618819. DOI: 10.3390/cells10113096.


First Use of Thermal Stabilized Hyaluronic Acid Injection in One-Year Follow-Up Patients with Genitourinary Syndrome.

Garavaglia E, Sala C, Busato M, Bellia G, Tamburlin N, Massirone A Med Devices (Auckl). 2020; 13:399-410.

PMID: 33304110 PMC: 7723235. DOI: 10.2147/MDER.S275966.


Hyaluronic Acid-Mediated Drug Delivery System Targeting for Inflammatory Skin Diseases: A Mini Review.

How K, Yap W, Lim C, Goh B, Lai Z Front Pharmacol. 2020; 11:1105.

PMID: 32848737 PMC: 7397973. DOI: 10.3389/fphar.2020.01105.


References
1.
Ghazi K, Deng-Pichon U, Warnet J, Rat P . Hyaluronan fragments improve wound healing on in vitro cutaneous model through P2X7 purinoreceptor basal activation: role of molecular weight. PLoS One. 2012; 7(11):e48351. PMC: 3500239. DOI: 10.1371/journal.pone.0048351. View

2.
Stratis A, Pasparakis M, Rupec R, Markur D, Hartmann K, Scharffetter-Kochanek K . Pathogenic role for skin macrophages in a mouse model of keratinocyte-induced psoriasis-like skin inflammation. J Clin Invest. 2006; 116(8):2094-104. PMC: 1525004. DOI: 10.1172/JCI27179. View

3.
Ohtani T, Memezawa A, Okuyama R, Sayo T, Sugiyama Y, Inoue S . Increased hyaluronan production and decreased E-cadherin expression by cytokine-stimulated keratinocytes lead to spongiosis formation. J Invest Dermatol. 2009; 129(6):1412-20. DOI: 10.1038/jid.2008.394. View

4.
Brown M, Martin G, Jones S, Akomeah F . Dermal and transdermal drug delivery systems: current and future prospects. Drug Deliv. 2006; 13(3):175-87. DOI: 10.1080/10717540500455975. View

5.
Barnes L, Ino F, Jaunin F, Saurat J, Kaya G . Inhibition of putative hyalurosome platform in keratinocytes as a mechanism for corticosteroid-induced epidermal atrophy. J Invest Dermatol. 2012; 133(4):1017-26. DOI: 10.1038/jid.2012.439. View